Cosette Pharmaceuticals, Inc.

DCAT 2025 is here! ?? Join our Business Development Executive, Jocelyn Larose, today at DCAT in New York City. This is the perfect opportunity to learn why you should partner with one of the largest US suppository manufacturers to get your semi-solids, liquids, oral suspensions and suppositories to patients faster. We've been in your shoes. So, we can overcome your challenges. We pull together the right team of experts, troubleshoot potential supply issues and mitigate them before they occur, so we can help ensure your project stays on track. Learn more at DCAT or get in touch here: www.cosettepharma.com/cdmo #CDMO #DCATWeek2025 #DCAT #PharmaceuticalManufacturing #DrugDevelopment #Semisolids #Suspensions #Suppositories

At?Cosette Pharmaceuticals, Inc., we celebrate the brilliant women who drive?innovation, leadership, and excellence?in pharmaceuticals. Today, on?International Women’s Day, we recognize the contributions of our female colleagues, partners, and healthcare professionals who are shaping the future of healthcare. ?Join us in celebrating the women who make a difference every day! #InternationalWomensDay #IWD2025 #InspireInclusion #WomenInPharma

Connect with Cosette CDMO at DCAT Week 2025 in New York City! Join our Business Development Executive, Jocelyn Larose, at DCAT to discuss your pharmaceutical development and manufacturing needs. Jocelyn will help you to explore how we can navigate the complex journey of bringing your?semi-solids, liquids, oral suspensions and suppositories to market with our CDMO expertise, proven track record and collaborative approach. DCAT is the perfect chance to tap into our experience as one of the largest US suppository manufacturers to get your product to patients faster. Reach out to Jocelyn directly or contact us here: www.cosettepharma.com/cdmo #CDMO #PharmaceuticalManufacturing #DrugDevelopment #Semisolids #Suspensions #Suppositories

This week, the Cosette team is attending the 2025?International Society for the Study of Womens Sexual Health (ISSWSH) and the?International Society for Sexual Medicine (ISSM) Joint Meeting. This is a fantastic opportunity for a diverse cross section of professionals to share the latest research, education, and best practices in women’s sexual health. Most importantly, the connections created at this meeting will advance the diagnosis and treatment of women’s sexual dysfunction as we work to improve the lives of women across the U.S. Cosette Pharmaceuticals, Inc.?will also be sharing new data on hypoactive sexual desire disorder (HSDD), the most common female sexual dysfunction condition in the U.S. which impacts 6 million premenopausal women. Despite being a recognized medical condition for over 40 years, HSDD is widely underdiagnosed and undertreated. “At Cosette, we have a deep commitment to improving women’s health, and this starts with increasing awareness and education in collaboration with the broader healthcare community,” said Kevin Hickey, VP Brand Sales & Marketing of Cosette. To learn more about our treatment for HSDD in premenopausal women, and the work we’re doing in women’s health, please visit our website: https://lnkd.in/esfae7Qw.

Why would you partner with Cosette CDMO for the following? ?? Product development ?? Technical transfer ?? Scale-up ?? Manufacturing ?? Packaging ?? Serialization/aggregation ??? Stability programs ?? Microbial testing ?? Raw materials testing Because you'll gain a partner with a deep understanding of formulation development and manufacturing challenges who has walked in your shoes before. You can also expect customized approaches to meet your specific product needs and guidance and expertise throughout your development journey. Let's collaborate to bring your next product to market: www.cosettepharma.com/cdmo #CDMO #PharmaceuticalManufacturing #DrugDevelopment #Semisolids #Suspensions #Suppositories

Today marks a transformational step for Cosette Pharmaceuticals, Inc. with our agreement to acquire 100% of Mayne Pharma for approximately USD $430 million, propelling Cosette into one of the leading companies in women’s health and dermatology in the U.S. Mayne’s highly complementary business strengthens our portfolio with patented, high-growth products and expands our reach globally. Together, the combined company will be well positioned to further accelerate innovation, expand access to critical therapies, and drive greater impact for patients. This marks an exciting new chapter as we continue to shape the future of women’s health and dermatology. Learn more: https://lnkd.in/ebNeGWHm. ? #CosettePharma #WomensHealth #Dermatology #Healthcare #Pharma #Acquisition Avista Healthcare Partners Hamilton Lane Hayfin Capital Management LLP Ropes & Gray LLP Corrs Chambers Westgarth Santander UBS Investment Bank Jefferies Gilbert + Tobin Arnold & Porter

We are looking forward to connecting with everyone at the upcoming DCAT (Drug, Chemical & Associated Technologies Association) week 2025 in New York City! Learn more about how Cosette Pharmaceuticals, Inc. is making a difference in healthcare, and how we Innovate Every Day. We look forward to meeting you! #healthcare #pharma #conference #dcatweek #dcat

We are excited to announce that Vin Colicchio joined us as Senior Vice President, Operations.?In this role, Vin will lead?Cosette’s manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its?strong trajectory of growth and transformation. Vin brings?more than 35+ years of leadership in pharmaceutical manufacturing and supply chain operations, spanning?semi-solids, liquids, oral solids, and transdermals in both?branded and generic markets. His experience at large-scale U.S. manufacturing and global supply chain operations will play a critical role as we continue to advance our capabilities and expand our portfolio. Please join us in wishing Vin continued success @Cosette!” ? For more details, please see the press release here https://bit.ly/3CNjMez ? #healthcare #pharma #manufactuing #operations #newhire #newleader

As part of Cosette Pharmaceuticals, we've walked the same path as you, facing the challenges of drug development and manufacturing. That's why we've built a CDMO with the expertise and capabilities to help you overcome those challenges and bring your products to market faster. With years of experience in the pharmaceutical industry, we've innovated every step of the way. Here's a reminder of our CDMO services: ? Product development ? Technical transfer? ? Scale-up ? Manufacturing ? Packaging ? Serialization/aggregation ? Stability programs ? Microbial testing ? Raw materials testing Whether you're in the early stages of development or ready for commercial production, we can provide the support you need to succeed. Learn more about our CDMO services at: www.cosettepharma.com/cdmo #CDMO #PharmaceuticalManufacturing #DrugDevelopment #Semisolids #Suspensions #Suppositories

We are excited to announce that Bradley D Leonard has joined us as Vice President, Commercial Operations! In this role, Brad will spearhead Cosette’s generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as Cosette continues its?expansion in these markets. With 30+ years of experience in the pharmaceutical industry, Brad is an experienced pharmacetical executive with a robust background in access and patient delivery across both generic and branded markets, cultivating and sustaining strong customer relationships, developing award-winning commercialisation teams, and consistently driving sales and profit growth. Please join us in wishing Brad continued success @Cosette! ? For more details, please see the press release here https://bit.ly/3Q0947k ? #healthcare #pharma #commercialization #newhire #newleader